Study Supports Tamoxifen for DCIS Early Breast Cancers
Drugs.com
DECEMBER 16, 2024
Mon.Dec 16, 2024
78 
Naughty or Nice? Many parents rely on threats to manage misbehavior -- from no dessert to no Santa
Science Daily: Pharmacology News
DECEMBER 16, 2024
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Oncology advances through the lens of women in STEM
Drug Target Review
DECEMBER 16, 2024
Dr Pooja Hingorani, Senior Medical Director of Oncology Early Development at AbbVie , shares her journey in STEM, from her early days in New Delhi to her impactful career in oncology research and drug development. Despite challenges as a woman in the field, Dr Hingorani built a career focused on advancing treatments for pediatric and adult cancers. In this interview, she discusses her path to becoming a physician and clinical researcher, the obstacles she faced, and her dedication to improving o
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Real Cost of Complexity: What Every Drug Developer Needs to Know
PPD
DECEMBER 16, 2024
Our annual look at the state of the drug development industry highlights a dual set of challenges complicating progress. The drug development industry faces rising costs and increasingly complex protocols as top challenges, with 49% of developers citing costs as their primary concern and 39% pointing to protocol complexity as a key hurdle, according to a recent survey of 150 drug developers worldwide by the PPD clinical research business of Thermo Fisher Scientific.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
More Trending
In vivo CAR T: Faster, cheaper, and more effective cancer care
Drug Target Review
DECEMBER 16, 2024
Since their first approvals in 2017, autologous CAR T-cell therapies have revolutionised the treatment of blood cancers, offering hope where previous options had failed. However, in their current ex vivo form, a patients cells are collected and then modified over weeks or months in a distant manufacturing site. Consequently, these therapies come with significant burdens and are often underutilised despite their transformative patient outcomes.
Does the exoplanet Trappist-1 b have an atmosphere after all?
Science Daily: Pharmacology News
DECEMBER 16, 2024
Google Patents: Why It’s a Risky Tool for Finding Drug Patents
Drug Patent Watch
DECEMBER 16, 2024
When it comes to researching and navigating the complex world of drug patents, inventors and researchers often turn to various tools to find relevant information. Google Patents, with its user-friendly interface and vast database, might seem like an ideal resource. However, there are several reasons why relying solely on Google Patents can be risky, especially in the context of pharmaceutical patents.
Universal Design for Visual Disabilities in Healthcare–Creating an Accessible Physical Environment-3
Perficient: Drug Development
DECEMBER 16, 2024
Welcome to our ongoing series on Universal Design for Healthcare! In this segment, well explore the importance of Visual Disabilities in Healthcare. Ensuring that healthcare facilities are physically accessible to individuals with visual disabilities is a key aspect of universal design. An accessible physical environment helps patients navigate spaces safely and independently, fostering a more inclusive and supportive healthcare experience.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Are we overlooking something critical in cell and gene therapy research?
BioPharma Drive: Drug Pricing
DECEMBER 16, 2024
Patient in Louisiana Hospitalized With First Bird Flu Case in That State
Drugs.com
DECEMBER 16, 2024
Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults in the US
Common Sense for Drug Policy Blog
DECEMBER 16, 2024
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Chronic Pain and High-Impact Chronic Pain in the US
Common Sense for Drug Policy Blog
DECEMBER 16, 2024
Jazz to search for new chief as CEO plans retirement
BioPharma Drive: Drug Pricing
DECEMBER 16, 2024
Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Novo builds up manufacturing; Pepgen Duchenne trial put on hold
BioPharma Drive: Drug Pricing
DECEMBER 16, 2024
Maximize Email Marketing with SFMC Email Studio
Perficient: Drug Development
DECEMBER 16, 2024
Email marketing remains a cornerstone for businesses aiming to connect with their audience effectively in the ever-evolving digital landscape. Salesforce Marketing Cloud’s Email Studio offers a robust platform to craft, personalize, and analyze email campaigns, ensuring that your messages resonate with recipients and drive meaningful engagement.
Edgewise weighs fast approval path for muscular dystrophy drug
BioPharma Drive: Drug Pricing
DECEMBER 16, 2024
Advanced Formik Techniques for Building Dynamic and Scalable Forms
Perficient: Drug Development
DECEMBER 16, 2024
Formik is an excellent tool for managing forms in React, simplifying state management and validation. However, as forms become more complex, you may need to dive into some advanced techniques. In this post, well cover how to handle dynamic fields, create custom validations, integrate with third-party UI libraries, and optimize performance. 1. Dynamically Adding and Removing Fields Sometimes, the number of form fields you need depends on user input.
Novo Holdings’ purchase of Catalent set to close after regulators’ green light
BioPharma Drive: Drug Pricing
DECEMBER 16, 2024
Universal Design for Visual Disabilities in Healthcare – The Importance of Universal Design -2
Perficient: Drug Development
DECEMBER 16, 2024
Welcome to our ongoing series on Universal Design for Healthcare! In this segment, well explore the importance of Visual Disabilities in Healthcare. Universal design in healthcare aims to create environments, products, and services that are inherently accessible to all individuals, including those with visual disabilities. Its importance cannot be overstated, as it ensures that everyone has equal access to healthcare, fostering an inclusive, equitable, and supportive environment.
Could the gut microbiome hold the key to fighting cancer?
BioPharma Drive: Drug Pricing
DECEMBER 16, 2024
Building Forms in React with Formik: A Simple Guide
Perficient: Drug Development
DECEMBER 16, 2024
Handling forms in React can get tricky, especially when managing complex states and validation. Formik is a popular library that simplifies this by managing form states, validations, and submissions with ease. In this guide, well explore how to set up a basic form using Formik. What is Formik? Formik is a small library for React forms. It helps manage form state and validation, making it easier to build reliable and maintainable forms.
When to Slow Down or Hit the Brakes on a Development Program
The Premier Consulting Blog
DECEMBER 16, 2024
New drug development is a long and expensive process that can be fraught with obstacles, including unexpected delays, poor efficacy results, safety issues, or regulatory challenges. Pharmaceutical companies may, at times, find themselves at an impasse during development, facing weighty decisions about whether to slow down or hit the brakes on a development program.
Transform Mobile Marketing with SFMC Mobile Studio
Perficient: Drug Development
DECEMBER 16, 2024
In today’s mobile-centric world, effective marketing requires reaching customers through their preferred devices. Salesforce Marketing Cloud Mobile Studio empowers businesses to engage customers via SMS, push notifications, and group messaging, ensuring timely and personalized interactions. This blog explores Mobile Studio’s features, benefits, and practical applications, providing insights into how it can enhance your mobile marketing strategy.
An insight on Mark and Sweep algorithm
Perficient: Drug Development
DECEMBER 16, 2024
As a developer, understanding how Mark and Sweep algorithm in JavaScript helps to write an efficient code Memory Management: A memory allocation will be created for all the variables, objects, functions we declare in the code. The memory heap is the place where all these memories are stored. This is constantly in sync with the call stack. Once the execution phase starts, there will be a read/write operation for that memory once it is done with the execution that part of the memory location need
FDA’s Third Party Review Program is Ready for the Next Pandemic, not the LDT Final Rule
FDA Law Blog: Biosimilars
DECEMBER 16, 2024
By Adrienne R. Lenz, Principal Medical Device Regulation Expert FDA recently released 510(k) Third Party Review Program and Third Party Emergency Use Authorization (EUA) Review which finalizes the draft guidance of the same title issued in December 2023. We previously discussed the Third Party Review Program in a blog post last year when FDA mentioned its expansion as part of its plan to address the resource gap for review of laboratory developed tests (LDTs) under the LDT final rule.
Let's personalize your content